SPIF ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
95自己免疫性肝炎2

95. 自己免疫性肝炎


臨床試験数 : 52 薬物数 : 68 - (DrugBank : 28) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 112
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03593460
(ClinicalTrials.gov)
January 1, 20197/6/2018Phase II AutoImmune HepatitisPhase II, Open Label, Adaptive Design, Multiple Dose Finding Study to Investigate Synthetic PreImplantation Factor (sPIF) in Patients With Autoimmune Hepatitis (AIH)Hepatitis, AutoimmuneDrug: Synthetic PreImplantation FactorChristopher O'Brien, MDBioIncept LLCWithdrawn18 Years75 YearsAll0Phase 2NULL
2NCT02239562
(ClinicalTrials.gov)
November 14, 201410/9/2014sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITISA Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Synthetic PreImplantation Factor (sPIF) in Autoimmune HepatitisAutoimmune HepatitisDrug: sPIF;Drug: PlaceboChristopher O'Brien, MDBioIncept LLCCompleted18 Years70 YearsFemale36Phase 1United States